摘要:
Restenosis of arteries after angioplasty in inhibited by implanting in the treated artery a stent (100) having the struts (102) coated with a composition including a statin (106) having anti-restenotic activity. Such statins may also be incorporated in a collagen or polymer matrix (106) that forms a coating covering the struts (102) and interstices (104) of the stent (100).
摘要:
Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. These therapeutic drugs, agents or compounds may also further reduce a biological organism's reaction to the introduction of the medical device to the organism. In addition, these therapeutic drugs, agents and/or compounds may be utilized to promote healing, including the formation of blood clots. Various materials and coating methodologies may be utilized to maintain the drugs, agents or compounds on the medical device until delivered and positioned. In one embodiment an intraluminal medical device comprises a scaffold structure having a luminal surface and an abluminal surface; a first layer affixed to the luminal and abluminal surfaces, the first layer including at least one first therapeutic agent; and a second layer affixed to the first layer, the second layer including at least one second therapeutic agent in combination with a water soluble polymeric material and a water insoluble polymeric material.
摘要:
A multi-step method of manufacturing a medical device containing therapeutic agents that results in a lower maximum error in the amount of therapeutic agents actually disposed thereon and that allows for differential drug release kinetics along the length of the medical device.
摘要:
A intravascular, interstitial or intraorgan medical device, and a manufacturing process of said medical device, is provided that allows for prevention of infection and obtainment of anti-thrombotic effect. The medical device comprises a nitric oxide (NO) eluting polymer arranged adjacent mammal tissue, such that a therapeutic dose of nitric oxide is eluted from said nitric oxide eluting polymer to said mammal tissue.
摘要:
The invention relates to the use of a zwitterionic detergent in order to reduce complement activation on a plastic surface provided with a coating made of an ionic complex of an anionic heparin or heparin derivative and cationic surfactant. The invention also relates to a corresponding method for reducing complement activation on plastic surfaces, in addition to a medical device comprising at least one of said coated plastic surfaces.
摘要:
The invention relates to a prosthesis comprising a proximal and a distal end and a hollow space that extends therebetween. Said prosthesis is provided with a support structure and at least one biologically active compound.
摘要:
The present invention provides a substrate having a plurality of immobilised furanone moieties associated with at least part of a surface of the substrate. The invention also relates to articles consisting of or comprising such a substrate.